Search research articles
Contact Us
Filters
Showing results (221-230 of 459) with videos related to
Page
of 46
Sort By:
International Journal of Cancer
|
December 16, 2025
Reply to: Comments on "Toxicity-related immunotherapy discontinuation and outcome in patients with advanced renal cell carcinoma treated with immune-based combinations (ARON-1 study)"
Javier Molina-Cerrillo, Giandomenico Roviello, Ondrej Fiala, et al.
International Journal of Cancer
|
December 3, 2013
The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-2
Maria Beatrice Morelli, Massimo Offidani, Francesco Alesiani, et al.
Journal of Nephrology
|
November 22, 2015
Transplantation of kidneys with tumors
Giovanni M Frascà, Antonia D'Errico, Deborah Malvi, et al.
Frontiers in Oncology
|
April 27, 2019
Circulating Tumor Cells in Renal Cell Carcinoma: Recent Findings and Future Challenges
Matteo Santoni, Alessia Cimadamore, Liang Cheng, et al.
European Urology Focus
|
November 2, 2020
Intraductal Carcinoma of the Prostate: Pathogenesis and Molecular Perspectives
Yang Zong, Rodolfo Montironi, Francesco Massari, et al.
Cancer Treatment Reviews
|
February 2, 2016
AR-V7 and prostate cancer: The watershed for treatment selection?
Chiara Ciccarese, Matteo Santoni, Matteo Brunelli, et al.
Critical Reviews in Oncology/Hematology
|
March 2, 2026
When is immunotherapy too much? The case of favorable-risk metastatic renal cell carcinoma
Sebastiano Buti, Betty Dalla Valle, Alessandro Acunzo, et al.
Cancer Treatment Reviews
|
June 4, 2015
Toll like receptors and pancreatic diseases: From a pathogenetic mechanism to a therapeutic target
Matteo Santoni, Kalliopi Andrikou, Valeria Sotte, et al.
Human Vaccines & Immunotherapeutics
|
December 19, 2024
State of the art of adjuvant immunotherapy in urothelial cancer: New developments and upcoming changes
Elisa Tassinari, Linda Danielli, Andrea Marchetti, et al.
The International Journal of Biological Markers
|
June 26, 2015
HER family receptor expression and prognosis in pancreatic cancer
Alessandro Bittoni, Alessandra Mandolesi, Kalliopi Andrikou, et al.
Page
of 46
Search research articles
Search
Showing results (221-230 of 459) with videos related to
Sort By:
Page
of 46
International Journal of Cancer
|
December 16, 2025
Reply to: Comments on "Toxicity-related immunotherapy discontinuation and outcome in patients with advanced renal cell carcinoma treated with immune-based combinations (ARON-1 study)"
Javier Molina-Cerrillo, Giandomenico Roviello, Ondrej Fiala, et al.
International Journal of Cancer
|
December 3, 2013
The effects of cannabidiol and its synergism with bortezomib in multiple myeloma cell lines. A role for transient receptor potential vanilloid type-2
Maria Beatrice Morelli, Massimo Offidani, Francesco Alesiani, et al.
Journal of Nephrology
|
November 22, 2015
Transplantation of kidneys with tumors
Giovanni M Frascà, Antonia D'Errico, Deborah Malvi, et al.
Frontiers in Oncology
|
April 27, 2019
Circulating Tumor Cells in Renal Cell Carcinoma: Recent Findings and Future Challenges
Matteo Santoni, Alessia Cimadamore, Liang Cheng, et al.
European Urology Focus
|
November 2, 2020
Intraductal Carcinoma of the Prostate: Pathogenesis and Molecular Perspectives
Yang Zong, Rodolfo Montironi, Francesco Massari, et al.
Cancer Treatment Reviews
|
February 2, 2016
AR-V7 and prostate cancer: The watershed for treatment selection?
Chiara Ciccarese, Matteo Santoni, Matteo Brunelli, et al.
Critical Reviews in Oncology/Hematology
|
March 2, 2026
When is immunotherapy too much? The case of favorable-risk metastatic renal cell carcinoma
Sebastiano Buti, Betty Dalla Valle, Alessandro Acunzo, et al.
Cancer Treatment Reviews
|
June 4, 2015
Toll like receptors and pancreatic diseases: From a pathogenetic mechanism to a therapeutic target
Matteo Santoni, Kalliopi Andrikou, Valeria Sotte, et al.
Human Vaccines & Immunotherapeutics
|
December 19, 2024
State of the art of adjuvant immunotherapy in urothelial cancer: New developments and upcoming changes
Elisa Tassinari, Linda Danielli, Andrea Marchetti, et al.
The International Journal of Biological Markers
|
June 26, 2015
HER family receptor expression and prognosis in pancreatic cancer
Alessandro Bittoni, Alessandra Mandolesi, Kalliopi Andrikou, et al.
Page
of 46